Global Health IPO Details
Issue Date
--
Price Range
₹319 - ₹336
Lot Size
--
IPO Size
₹2205.57 Cr
Global Health IPO Listing Details
Listing On
16 Nov'22
Issue Price
₹336
Listed Price
₹ 401
Retail Gain/Listing Gain
▲19.35%
Schedule of Global Health IPO
Start date
End date
Allotment of bids
Refund Initiation
Listing on exchange
16/11/2022
Company Background
Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues amongst the players that operate in the North and East regions of India (as of and for the financial year ended March 31, 2022). The company operates in key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology (according to CRISIL Report).
Under the “Medanta” brand, the company has a network of five hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna) and one hospital (Noida), which is under construction.
The company is founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon, awarded with the Padma Bhushan and the Padma Shri, the third and fourth-highest civilian awards in India.
In Fiscal 2021, the company expanded the outpatient department pharmacies in-house at the Gurugram, Lucknow, Indore and Ranchi hospitals, and launched outpatient department pharmacy at south Delhi clinic and home care services in Gurugram and New Delhi. Further expansion happened with the company’s home-care services, which have scaled up the telemedicine and remote delivery of healthcare services, and the monthly average consultation via video and telephone in Gurugram increased by 1,419.33% from 419 in Fiscal 2020 to 6,366 in Fiscal 2021 and by 33.60% to 8,505 in Fiscal 2022, and 5,070 in the three months ended June 30, 2022.
In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs 14,805.71 million, Rs 14,178.41 million, Rs 21,003.95 million, Rs 4,732.10 million and Rs 5,960.89 million, respectively.
Competitive Strengths
Recognised tertiary and quaternary care provider in India
Track record of operational and financial performance
Focus on under-served areas with dense population and presence in top or capital cities of large states
Large-scale hospitals with sophisticated infrastructure, medical equipment and technology:
Key Strategies
Here are a few strategies Global Health (Medanta) Limited has for its business:
- Continue to invest in bed capacity expansion in existing facilities and develop further super-specialities, employ new technology and focus on preventive healthcare
- Continue to attract, engage and train prominent, skilled doctors and other healthcare professionals
- Enhance clinical capabilities and improve operating efficiencies
- Extend clinical services outside the hospital and across the lifetime of the patient
- Leverage technology to improve patient experience and grow digital health services
- Build on thought leadership through increased focus on academics and research
Key Financials
And finally here’s a look at key financials of Global Health (Medanta) Limited.
How to apply for IPO through ASBA
00m 58s
Trending IPOs
31 Dec - 02 Jan'26 | |||||||||
To be announced | |||||||||
To be announced | |||||||||
To be announced | |||||||||
To be announced | |||||||||
Global Health IPO FAQs
Trending IPOs
31 Dec - 02 Jan'26 | |||||||||
To be announced | |||||||||
To be announced | |||||||||
To be announced | |||||||||
To be announced | |||||||||